Campath-1H

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

Anti-Human CD45 Monoclonal Antibodies in Patients With Advanced Leukemia Prior to Allogeneic Stem Cell Transplantation

Allogeneic Transplantation For Severe Osteopetrosis

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

Hematopoietic Stem Cell Support in Vasculitis

Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia

Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism

Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders

T-Reg Cell Kinetics, Stem Cell Transplant, REGALE

Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

Campath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders

Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic Leukemia